Nathalie Maubon
Nathalie Maubon has more than 20 years' experience in pharmaceutical research, having worked at public research, pharmaceutical and biotechnology companies. She is a specialist in the development and automation of robust models for high-throughput screening. Maubet is the President and Scientific Director of HCS Pharma, leading the development of new biological models for research and testing.
More content by Nathalie Maubon
Meet Pharma IQ’s advisory board: Nathalie Maubon
November 08 by Leila Hawkins
Pharma IQ’s advisory board member Nathalie Maubon on the future of drug testing
The latest in cancer treatments: Recreating the tumor environment
April 28 by Leila Hawkins
Pharma IQ speaks to HCS Pharma about creating the technology that reproduces tumor microenvironments to treat cancer
